|
Aptilon Announces Expanded Contracts
|
Montreal, QUEBEC, September 4, 2008 - Aptilon Corporation (“Aptilon” or the “Corporation”) (TSX-V: APZ), an innovative leader of online marketing services to physicians, today announced the extension and expansion of contracts with its largest client for the sixth consecutive year and another top 10 U.S. pharmaceutical manufacturer for the second year. Under terms of the agreements, which commence in 2008 and extend for 12 months, Aptilon is connecting high profile physicians with an increased number of pharmaceutical brands. Up to $5 million of work will be delivered under these performance-based contracts with the possibility that additional services will be added.
|
Chairman and CEO Dr. Roger Korman stated, “By extending our market lead in providing live video connectivity to physicians, Aptilon further entrenches its position in top US pharmaceutical companies. The expansion of these client commitments strengthens Aptilon’s ability to grow organically through sustainable repeat. Clients are renewing their commitments to Aptilon on the basis of the measurable results they achieve.”
The contracts center on Aptilon providing its AxcelRxSM “click to talk” video connection software so that doctors can connect to pharmaceutical service representatives through a live video link at their convenience. Aptilon has demonstrated these sales representative-physician dialogues last on average more than eight minutes, which is considerably longer than the typical encounter in the office.
Dr. Korman added, “Our recent acquisitions have enabled us to reach an expanded number of high profile US physicians who benefit from the kinds of programs offered by innovative pharmaceutical companies. Physicians are looking for an efficient means to get the drug information they require and, in these days of cost constraint, top US pharmaceutical companies are searching for the optimal deployment of their promotional resources. Aptilon AxcelRxSM platform meets both their needs.” |
|
About Aptilon Corporation
Aptilon enables pharmaceutical, biotech and medical device companies to effectively reach and interact with more than 450,000 US physicians via the Internet through its innovative AxcelRxSM Live video detailing platform which hosts promotional, peer selling and other sales and marketing programs. Top ten US pharmaceutical companies have adopted Aptilon’s AxcelRxSM solution to reach leading physicians. Aptilon provides the infrastructure necessary for pharmaceutical companies to build physician awareness, understanding, and product preference during all stages of a product’s life cycle, from pre-launch education through end stage support. For more information, visit www.aptilon.com.
AxcelRxSM and ReachNetSM are service marks of Aptilon Corporation.
|
-##-
The TSX Venture Exchange Inc. has not reviewed and does not accept responsibility for the adequacy or
accuracy of this release.
|
|
